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 ORIGINAL ARTICLE 
 Early experiences with the multidose drug dispensing 
system – A matter of trust? 
 LIV JOHANNE  WEKRE 1,2,3 ,  LINE  MELBY 3  &  ANDERS  GRIMSMO 1,3 
 1 Department of Community Medicine and General Practice, Norwegian University of Science and Technology (NTNU), 
Trondheim, Norway,  2 Central Norway Hospital Pharmacy Trust, Trondheim,  3 Norwegian EHR Research Centre, 
Norwegian University of Science and Technology (NTNU), Trondheim, Norway 
 Abstract 
 Objective. To study early experiences with multidose drug dispensing (MDD) among different groups of health personnel. 
 Design. Qualitative study based on focus-group interviews.  Setting. Primary health care, Trondheim, Norway.  Main outcome. 
The importance of trust in the technology and in collaborating partners is actualized in the early implementation of MDD. 
 Results. GPs, home-care nurses, pharmacists, and medical secretaries trusted the new MDD technology. The quality of the 
GPs ’ medication records improved. However, health personnel, including the GPs themselves, would not always trust the 
medication records of the GPs. Checking the multidose bags arriving from the pharmacy was considered unnecessary in 
the written routines dealing with MDD. However, home-care nurses experienced errors and continued to manually check 
the bags. Nurses in the home-care service felt a loss of knowledge with regard to the patients ’ medications and in turn 
experienced reduced ability to give medical information to patients and to observe the effects of the drugs. The home-care 
services ’ routines for drug handling were not always trusted by the other groups of health personnel involved.  Conclusion. 
Health personnel faced some challenges during the implementation of the MDD system, but most of them remained 
confi dent in the new system. Building trust has to be a process that runs in parallel with the introduction of 
new technology and the establishment of new routines for improving the quality in handling of medicines and to facilitate 
better cooperation and communication. 
 Key Words:  Drug packaging ,  family practice ,  home-care services ,  information sharing ,  medication errors ,  medication records , 
 pharmacy ,  trust 
 Multidose drug dispensing (MDD) is a  “ new ” expansive 
fi eld in the Scandinavian countries, both in the 
community care settings and in the nursing home 
setting. MDD is recommended by health authori-
ties, motivated by expected savings in terms of med-
ication dispensing errors and drug expenses [1 – 3]. 
However, scientifi c evaluations are missing [3,4]. 
MDD implies that the patient receives drugs 
machine-dispensed into one unit for each dose occa-
sion, packed in disposable bags. The dose unit bags 
are labelled with patient data, drug contents data, 
and time for intake [5 – 7]. 
 MDD was implemented in the home-care 
services in Trondheim, Norway, in 2006. The 
implementation was accomplished in a complex 
organization including pharmacies, home-care services, 
and GPs ’ offi ces. At the time of implementation the 
home-care services were organized into 27 home-
care divisions in four town districts. A total of 137 GPs 
participated, and fi ve pharmacies were involved as 
MDD providers. The home-care service adminis-
trated drugs for approximately 1800 out of 3000 
patients receiving home-care. One of the major sup-
pliers of multidose drugs in Norway was responsible 
for the production of the new drug packages and 
distributing them to the pharmacies. In addition to 
dispensing the patients ’ multidose drugs to the dif-
ferent home-care divisions, the pharmacies were also 
charged with updating the medication record in the 
multidose provider ’ s database and making reviews of 
Scandinavian Journal of Primary Health Care, 2011; 29: 45–50
ISSN 0281-3432 print/ISSN 1502-7724 online © 2011 Informa Healthcare
DOI: 10.3109/02813432.2011.554002
 Correspondence: Liv Johanne Wekre, Department of Community Medicine and General Practice, Nowegian University of Science and Technology (NTNU), 
MTFS, 7491 Trondheim, Norway. E-mail: liv.j.wekre@ntnu.no 



































46 L. J. Wekre et al.
the patients ’ prescriptions whenever changes were 
made by the GP (in addition to an annual review). 
 A project group was appointed to prepare and 
assist the implementation process. Information dis-
semination was emphasized to create involvement, 
motivation, and commitment among the users. It was 
also requested that the home-care divisions and the 
pharmacies appointed a specifi c MDD contact per-
son to function as a contact point for the different 
organizations. 
 Unlike most other municipalities using MDD in 
Norway, Trondheim decided to use the GP ’ s medica-
tion record in the electronic health record (EHR) as 
the master medication record. Hence, other health 
personnel had to update the medication record in 
their own EHR in accordance with the GP ’ s medica-
tion record. Only the patient ’ s GP was allowed to 
prescribe drugs to be included in the multidose drug 
packages. 
 The aim of this project was to study early experi-
ences amongst the different groups of health profes-
sionals participating in the implementation of the 
MDD system. Several signifi cant issues were brought 
up during the interview sessions but, already at an 
early stage of analysing the data, trust stood out as 
an important concern in all groups. In this article we 
have explored in depth the users ’ experiences with 
the MDD related to trust  – in terms of both trust in 
the MDD system and trust within and between 
groups of collaborating health personnel. The users ’ 
experiences with the MDD system covered the han-
dling of drugs from prescribing to administration of 
drugs to the patient. 
 Material and methods 
 Four focus-group interviews were carried out in 
March 2007, about one year after the introduction of 
MDD. We performed a careful selection of health 
personnel with varied MDD experience; the selection 
spanned different workplaces and personnel with 
different roles in the handling of MDD, thus obtain-
ing data-source triangulation [8]. The four groups 
contained six home-care nurses, fi ve pharmacists, six 
GP medical secretaries, and seven GPs. The focus-
group interviews lasted from 70 to 110 minutes. 
 A master ’ s student in sociology, trained in con-
ducting focus-group interviews, opened and moder-
ated the interviews. The moderator used an interview 
guide tailored to each group, but with some themes 
common to all of the groups (Table I). During the 
interviews the informants shared experiences and 
refl ections related to the implementation and use of 
MDD. The interviews were observed and videotaped 
by the fi rst author. Afterwards the interviews were 
transcribed verbatim by the moderator and checked 
by the fi rst author. 
 Data were analysed by the authors through sys-
tematic text condensation, an approach described 
by Giorgi [9] and modifi ed by Malterud [10]. We 
started the analysis by using the themes from the 
interview guide as point of departure for defi ning 
key categories. However, the issue of trust distin-
guished itself as a theme that was raised by many of 
our informants. This led us to adopt trust as a gov-
erning idea throughout the analysis. This emphasis 
on trust from the informants when refl ecting on 
their experiences with MDD is thus a result in itself, 
but was also used to structure our analysis. 
 Observation triangulation was achieved through 
independent analysis of the transcribed interviews by 
 Table I. Themes in the interview guides and example questions from the focus-group interviews. 
Themes Example questions
Implementation and organizational development How did the implementation of multidose progress?
How did the implementation change the distribution of work at your workplace?
Cooperation and communication How is the fl ow of information between you and the home-care service? (question 
directed to doctors, medical secretaries, and pharmacists)
What can be improved with regard to communication?
Patient safety and time use In what way does use of the multidose dispensed drugs infl uence patient safety?
Do you take up more time on patients after the implementation of MDD? Why/
why not? (question directed to nurses in the home-care services)
Trust is an important issue for health personnel 
in an early phase of the implementation of a mul-
tidose drug dispensing (MDD) system:
Trust in the MDD system was challenged  •
by medication records being outdated and 
the loss of fl exibility in choosing and dosing 
drugs.
Changes in routines and roles required a  •
higher level of trust between professionals.
Home-care nurses feared a loss of compe- •
tence in following up patients and drug 
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the three authors [8]. The fi rst and third author have 
extensive clinical experience in the fi eld as a commu-
nity pharmacist and former GP, respectively. In addi-
tion the second and third author have experience 
from research on collaboration in health care as 
respectively a social scientist and a public health 
researcher. 
 Results 
 Trust  – both in the MDD system and in colleagues – was 
a central issue for all the informants when discussing 
their experiences related to MDD. 
 Trust in the MDD system 
 Most of the participants expressed positive atti-
tudes towards the MDD system, and frequently  – 
either directly or indirectly  – related it to trust. In 
general it was expected that the MDD system 
would lead to more trustworthy handling of drugs 
and fewer dispensing errors, as illustrated by the 
following quote: 
 I know someone  … who told me that the mother 
became completely healthy when she began with 
this [multidose dispensed drugs]. She stopped the 
stumbling and lurching and everything. So it turns 
out that she must have been mixing. She became a 
new person … . Because when she got what she was 
supposed to get, at the right time  … it didn ’ t take 
long  … before they said,  “ now, she is in such good 
health ” . (Medical secretary) 
 However, one of the nurses explained that they 
kept on checking the multidose drug packages as 
they arrived from the pharmacy. This was done 
even though it was considered unnecessary in the 
written routines handed out with the implementa-
tion of MDD and may indicate that they did not 
really have complete trust in the MDD system 
after all. 
 Prescriptions of drugs with an interim change 
in dosage and as an interim cure were considered 
problematic in the MDD system, as was handling of 
warfarin: 
 … when it comes to short adjustments of medications 
and adjustments of furosemide in a short period or 
a cure, it is in many cases more diffi cult to go through 
with after the implementation of MDD. (GP) 
 I think warfarin has been a diffi cult thing. I had 
a patient who had an incorrect warfarin dosage 
for eight weeks due to failure in MDD. And what 
happened I do not really know  … (GP) 
 The quotes indicate that the MDD system is 
perceived as less fl exible when it comes to changes 
in medication/dosage than the old, manual system. 
 Moreover, all the groups of health personnel faced 
an increased need for cooperation and communication 
among themselves during the implementation of MDD. 
The fact that the MDD system required more com-
munication and stronger involvement of the GPs and 
in particular the pharmacies can be interpreted as 
caused by health personnel not completely trusting the 
system. One of the GPs said that he regarded  “ the phar-
macy as a safety net in terms of dosages to patients ” , 
illustrating the important role of the pharmacy in creat-
ing a trustworthy system for MDD. 
 Trust among the other groups of health personnel 
 Errors made in the home-care service after the imple-
mentation of MDD were reported both by pharma-
cists and by GPs. 
 In the case I was talking about, it was one 
[a home-care nurse] who gave an antidepressant 
that was discontinued. The doctor thought he ’ d try 
a new type, which was packaged in the MDD, 
but the home-care gave the other in addition. 
(Pharmacist) 
 These and similar observations challenged the trust 
in the routines of the home-care services. The coop-
erating professions did not always trust the GP ’ s 
updates to the medication record either. The medica-
tion records were needed for prescriptions of multi-
dose drugs. Home-care nurses experienced diffi culties 
with getting in touch with GPs in order to make them 
update and hand over medication records. 
 [Cooperation with] the pharmacies works very 
smoothly. Doctors, too, but it takes time … . That ’ s the 
problem; they may not call back. (Nurse) 
 The GPs and the medical secretaries confi rmed the 
problems and blamed insuffi cient information and 
follow-up from the project group responsible for 
implementation. The pharmacists also experienced 
insuffi cient updates of the medication records by the 
GPs. 
 I called the doctor and received the prescription over 
the phone. Next time we got it [the medication record] 
the doctor had not changed it. The doctor only said 
yes on the phone … . That ’ s why we agreed to get 
everything [new prescriptions] in writing. The doctor 
now faxes us. (Pharmacist) 
 GPs and nurses stated that the implementation of 
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concerning which drugs should be adminis tered 
 “ as required ” (pro re nata). For practical reasons 
the home-care wanted as much as possible to be 
packed in the multidose bags while the GPs often 
wanted some drugs, such as sleeping pills, to be 
taken only when required. Both parties were 
 content with this increased level of dialogue, as it 
in the end is benefi cial to the welfare of the 
patient. 
 Trust within the different groups of health personnel 
 The home-care nurses were concerned about the 
reduction in manual dispensing of drugs. They feared 
that this would decrease their knowledge of patients ’ 
health in relation to his/her drug intake, and make 
them, as a group, less trusted concerning these ques-
tions. A nurse said: 
 I guess we had better overview before [the introduc-
tion of MDD] … . Now, of course we have lost it, and 
then I think in the long run I will lose the overview 
over the patient ’ s condition … . Also, when you sit and 
dose medicines manually, you think and refl ect on 
the patient you are dosing for … . Then you sit and 
think about how it works for him and:  “ This should 
have been checked, and is it really necessary to take 
this [drug]? ” Now I hardly refl ect on it, and that ’ s 
a little scary. (Nurse) 
 However, both the pharmacists and the GPs experi-
enced a greater infl uence on drug dispensing, and 
they both argued for improved quality in the han-
dling of drugs after the implementation of MDD. 
This happened despite the fact that the doctors 
admitted that not all GPs work at the same level of 
accuracy with regard to medication records, in effect 
saying that not all GPs ’ medication records were to 
be trusted: 
 … doctors have varying levels of accuracy, then. 
Some are very accurate and some are not. It is much 
more comfortable to be a stand-in for the doctors who 
are relatively accurate than for the others. (GP) 
 The medical secretaries also confi rmed this: 
 Yes, there have been changes [in drug prescrip-
tions] and in and out of hospital, they [GPs] need 
to update them [the medical records] then. They 
have not always been so good at it previously. 
(Medical secretary) 
 The GPs believed that electronic communication 
could improve the exchange of information and 
updating, and thus produce an even better effect 
from the MDD system. 
 Discussion 
 This study has demonstrated that health personnel 
preserved trust in the MDD system even if the sys-
tem caused new errors and changes to the routines 
and roles of the health personnel involved. The 
impact of healthcare professionals ’ attitudes towards 
the new system and views concerning their own and 
others ’ roles are likely to affect the implementation 
process and outcome. 
 Limitations of the study 
 Focus-group interviews were conducted to get a bet-
ter understanding of the attitudes and experiences 
among involved health personnel in relation to imple-
mentation of MDD in the home-care services [11]. 
The results stem from a single implementation and 
any generalization of the fi ndings should be made 
cautiously. Successful implementation of a new tech-
nology in one organization might well become a 
failure in another [12]. 
 The fi rst author was observing the interviews. 
She was also a member of the project group respon-
sible for the implementation of MDD and has been 
a community pharmacist engaged in researching 
methods to reduce the number of medical errors in 
primary care. This might have infl uenced how the 
participants expressed their attitudes towards the 
MDD system and the implementation process, as 
well as the role of pharmacists. Observer triangula-
tion was used to diminish this risk of bias. 
 The timing of the interviews in relation to the 
implementation process also has to be considered. In 
an early phase of implementation, engagement and 
an optimistic attitude may infl uence the way the 
people involved describe a new system [13]. How-
ever, later on they might have adapted to problems 
by way of  “ work-arounds ” [14]. 
 New technology and the signifi cance of trust 
 The issue of trust stands out as important in respect 
of any system implementation [15]. The details 
surrounding the MDD system are mostly invisible 
to the health personnel, and the work put into it is 
to some extent also separated in both time and 
space from the end-users. Hence it may be under-
stood and analysed as an abstract (expert) system 
[16]. In addition, the implementation of systems 
and concurrent reorganization of work raise the 
issue of trust in colleagues. This makes it important 
to understand the relationship and interplay 
between system trust and personal trust to be able 
to understand the intra-organizational implemen-
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 We would argue that trust in the MDD system 
and the new professional roles were established 
through the implementation process. The imple-
mentation project succeeded in involving the 
affected health personnel in the planning of the new 
system. It established responsibility as well as new 
uniform collaboration routines. These are impor-
tant success factors, as underlined by others who 
have studied implementation of MDD systems 
[4,18]. However, we have not been able to fi nd any 
other studies explicitly discussing trust as an issue 
in drug dispensing. 
 The informants indicated a common expectation 
for the MDD system to reduce the discrepancies 
between medication records at the GPs ’ practices 
and in the home-care services. In a parallel study 
undertaken by the authors, their expectations were 
largely confi rmed [19]. Even so, health personnel 
remained confi dent in the new system even when 
coming across new types of errors caused by the 
introduction of MDD. Unfortunately, the introduc-
tion of new errors is quite common when new tech-
nology or changes in routines are introduced 
[20 – 23]. 
GPs indicated that they were content with the 
introduction of MDD. We know from earlier studies 
that GPs are not always conscientious in keeping up 
their medication records [24 – 26] and this was also 
reaffi rmed through the interviews. The GPs as well 
as the medical secretaries would not always trust the 
medication records of their GP colleagues. Some 
patients are well known to their GPs through con-
tinuous and frequent encounters over time and stud-
ies have shown that GPs are very rational both with 
regard to how and with regard to what they docu-
ment for their own sake in the EHR [27]. On the 
other hand, the GPs were pleased with the new and 
more extensive cooperation with the pharmacy intro-
duced by MDD. A recent study on the value of 
physician/pharmacist/nurse cooperation in nursing 
homes has shown impact on optimizing medication 
use [28]. 
 Nurses were anxious about losing their skills as 
good observers of patients. One could attempt to 
compensate for uncertainty in new technology either 
by keeping up old routines in parallel, or by trying to 
fi nd other ways of obtaining the same information [13]. 
Additionally, the tasks that belong to their role are 
many and integrated. Planners sometimes underesti-
mate the extent to which taking away one task might 
have unintended and negative effects on others [20]. 
The nurses might be justifi ed in expressing scepticism 
towards the new system [29]. On the other hand, 
some would claim that the discontent from the nurses 
is more about the protection of their own role rather 
than scepticism towards the MDD system. 
 Future research 
 The nursing role has previously been described as the 
last defence in a safety net to prevent errors [30]. Our 
group of nurses reported that less attention was paid 
to medications after the introduction of MDD. Instead 
the pharmacy was highlighted as a new safety net. 
More research is needed to look into the consequences 
of this potential change in responsibility. The signifi -
cance of new types of errors following the intro-
duction of MDD also needs further investigation. 
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